SARS-CoV-2 Antigen Test Kit - India CDSCO Medical Device Registration
SARS-CoV-2 Antigen Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000290_6e3009cd090d7d12638276efe9c8abc5_be68a53de5e71e6ae0c211863264b2d3. This device is marketed under the brand name LFIA. The license holder is Regulatory1, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
LFIA
License Holder
Regulatory1Device Class
Approving Authority
CDSCO
Product Information
SARS-CoV-2 antigen Test Kit (LFIA) is used to qualitatively detect SARS-CoV-2 inhuman samples in vitro.

